Home
Search
BIO International Convention   |   June 3-6, 2024

Speakers & Presenters

All Speakers
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Speakers
All Speakers
Filter by letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Results
Amin Al Ameeri
ASSISTANT UNDERSECRETARY OF HEALTH REGULATION SECTOR AT THE MINISTRY OF HEALTH AND PREVENTION, UNITED ARAB EMIRATES
Spurring Life Sciences Innovation Across The Globe: A High-Level Discussion
Mohammed Al-Bitar, MBA
ADVISOR, DEPARTMENT OF HEALTH
Department of Health - Abu Dhabi
Abu Dhabi, Abu Dhabi, United Arab Emirates
Tom Alapaattikoski
CEO, BRINTER INC
Brinter Inc
Santa Monica, California, United States
Philippe Alen, PharmD
HEAD OF BUSINESS DEVELOPMENET, GALAPAGAOS
Galapagos
Melchen, Antwerpen, Belgium
Lina Aljuburi, PharmD, MS
HEAD, REGULATORY SCIENCE POLICY NORTH AMERICA, SANOFI
Re-Imagining Drug Development and Regulatory Submissions through Cloud-Based Technologies
Michael Altorfer, PhD
CEO, SWISS BIOTECH ASSOCIATION
Swiss Biotech Association
Swiss Business Hub USA
Zürich, Zurich, Switzerland
Luis Alvarez, PhD
PRESIDENT & CEO, THERADAPTIVE, INC.
Theradaptive, Inc.
Frederick, Maryland, United States
Virginia Amann
CEO/FOUNDER, ENTENTE HEALTH & SCIENCE COMMUNICATIONS
New Strategies for Increasing Diversity in Clinical Trials
Jonathan Amaya-Hodges
DIRECTOR, TECHNICAL SERVICES, SUTTONS CREEK, INC.
Learn About the Latest Regulatory Advancements in Combination Products with a Focus on Risk Management
Stacy Amin, JD
FORMER FDA CHIEF COUNSEL, MORRISON FOERSTER
PDUFA VII and Beyond: Building Confidence in AI Tools as New “Gold Standards” for Drug Development
In Vitro Diagnostics Regulation in the US and Beyond: Trends and Strategies to Navigate Change
Washington, District of Columbia, United States